| 000 | 01874 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515060649.0 | ||
| 264 | 0 | _c20070606 | |
| 008 | 200706s 0 0 eng d | ||
| 022 | _a1340-3478 | ||
| 024 | 7 |
_a10.5551/jat.14.31 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSato, Yuki | |
| 245 | 0 | 0 |
_aPlatelet aggregability in patients with hypertension treated with angiotensin II type 1 receptor blockers. _h[electronic resource] |
| 260 |
_bJournal of atherosclerosis and thrombosis _cFeb 2007 |
||
| 300 |
_a31-5 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid _xtherapeutic use |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAngiotensin II Type 1 Receptor Blockers _xtherapeutic use |
| 650 | 0 | 4 |
_aBenzimidazoles _xtherapeutic use |
| 650 | 0 | 4 | _aBiphenyl Compounds |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xprevention & control |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xblood |
| 650 | 0 | 4 | _aLight |
| 650 | 0 | 4 |
_aLosartan _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 | _aPlatelet Aggregation Inhibitors |
| 650 | 0 | 4 | _aPlatelet Function Tests |
| 650 | 0 | 4 | _aScattering, Radiation |
| 650 | 0 | 4 |
_aTetrazoles _xtherapeutic use |
| 650 | 0 | 4 | _aTherapeutic Equivalency |
| 700 | 1 | _aFujii, Satoshi | |
| 700 | 1 | _aImagawa, Shogo | |
| 700 | 1 | _aOhmura, Kazue | |
| 700 | 1 | _aOhmura, Yoshinori | |
| 700 | 1 | _aAndoh, Yasuhiro | |
| 700 | 1 | _aDong, Jie | |
| 700 | 1 | _aIshimori, Naoki | |
| 700 | 1 | _aFurumoto, Tomoo | |
| 700 | 1 | _aTsutsui, Hiroyuki | |
| 773 | 0 |
_tJournal of atherosclerosis and thrombosis _gvol. 14 _gno. 1 _gp. 31-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.5551/jat.14.31 _zAvailable from publisher's website |
| 999 |
_c16889968 _d16889968 |
||